文献速递重症综合管理与镇静镇痛

ICU患者家属探视与精神疾病结局:一项基于人群的回顾性队列研究

Psychiatric Outcomes in ICU Patients With Family Visitation: A Population-Based Retrospective Cohort Study.
PubMed 文献 · Chest · 2022-03-07
一句话结论ICU住院期间家属探视与出院后1年内精神疾病诊断风险降低相关(RR 0.79,95%CI 0.68-0.92)。

该研究为基于人群的回顾性队列,纳入2014年1月1日至2017年5月30日入住ICU、存活出院且ICU停留≥3天的成人患者14,344例。采用内部验证的自然语言处理算法判定ICU期间有无家属(亲属、朋友)面对面探视,主要终点为出院后1年内新发精神疾病(焦虑、抑郁、创伤及应激相关、精神病性、物质使用障碍的复合终点)。倾向评分逆概率加权后,有家属探视与出院后1年内新发精神疾病诊断风险降低相关(RR 0.79;95%CI 0.68-0.92)。

要点

  • 在14,344例ICU存活出院患者中,96%(n=13,771)有家属面对面探视,4.0%(n=573)无探视。
  • 出院后1年内超过三分之一患者(34.9%;95%CI 34.1%-35.6%)被诊断任一精神疾病,最常见为焦虑障碍(17.5%;95%CI 16.9%-18.1%)和抑郁障碍(17.2%;95%CI 16.6%-17.9%)。
  • 对13,731例患者进行逆概率加权后,ICU家属探视与出院后1年内新发精神疾病诊断风险降低相关(RR 0.79;95%CI 0.68-0.92)。
  • ICU家属探视可能与危重症患者出院后长达1年的精神疾病风险降低相关。

适用人群与场景

  • 2014年1月1日至2017年5月30日入住ICU、存活出院且ICU停留时间≥3天的成人患者。
  • 需有ICU入住前至少5年行政数据及出院后至少1年随访数据。

诊断标准与关键阈值

  • 采用内部验证算法解析健康记录自然语言,判定ICU期间有无家属(即亲属、朋友)面对面探视。
  • 主要终点为出院后1年内新发精神疾病复合诊断,包括焦虑、抑郁、创伤及应激相关、精神病性、物质使用障碍,采用行政数据库编码算法识别。

研究设计与关键结果

  • 研究类型:基于人群的回顾性队列研究,纳入14,344例ICU存活出院患者,其中有家属面对面探视96%(n=13,771),无探视4.0%(n=573)。
  • 出院后1年内任一精神疾病诊断率34.9%(95%CI 34.1%-35.6%),焦虑障碍17.5%(95%CI 16.9%-18.1%),抑郁障碍17.2%(95%CI 16.6%-17.9%)。
  • 对13,731例患者进行逆概率加权后,家属面对面探视与出院后1年内新发精神疾病诊断风险降低相关(RR 0.79;95%CI 0.68-0.92)。

证据类型、等级与局限

  • 证据类型:基于人群的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ICU家属探视与危重症患者出院后长达1年的精神疾病风险降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Lack of family visitation in the ICU can have long-term consequences on patients in the ICU after discharge. The effect of family visitation on the incidence of patient psychiatric disorders is unknown.

RESEARCH QUESTION: What is the association between family visitation in the ICU and incidence of psychiatric outcomes in patients in the ICU 1 year after hospital discharge?

STUDY DESIGN AND METHODS: This study assessed a population-based retrospective cohort of adult patients admitted to the ICU from January 1, 2014, through May 30, 2017, surviving to hospital discharge with ICU length of stay of ≥ 3 days. To be eligible, patients needed to have minimum of 5 years of administrative data before ICU admission and a minimum of 1 year of follow-up data after hospital discharge. An internally validated algorithm that interpreted natural language in health records determined patients with or without in-person family (ie, relatives, friends) visitation during ICU stay. The primary outcome was risk of an incidence of psychiatric disorder (composite outcome), including anxiety, depressive, trauma- and stressor-related, psychotic, and substance use disorders, identified using coding algorithms for administrative databases. Propensity scores were used in inverse probability weighted logistic regression models, and average treatment effects were converted to risk ratios (RRs) with 95% CIs. Secondary outcomes were incidences of diagnoses by type of psychiatric disorder.

RESULTS: We included 14,344 patients with (96% [n = 13,771]) and without (4.0% [n = 573]) in-person family visitation who survived hospital discharge. More than one-third of patients received a diagnosis of any psychiatric disorder within 1 year after discharge (34.9%; 95% CI, 34.1%-35.6%). Patients most often received diagnoses of anxiety disorders (17.5%; 95% CI, 16.9%-18.1%) and depressive disorders (17.2%; 95% CI, 16.6%-17.9%). After inverse probability weighting of 13,731 patients, in-person family visitation was associated with a lower risk of received a diagnosis of any incident psychiatric disorder within 1 year after discharge (RR, 0.79; 95% CI, 0.68-0.92).

INTERPRETATION: ICU family visitation is associated with a decreased risk of psychiatric disorders in critically ill patients up to 1 year after hospital discharge.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Moss SJ, Rosgen BK, Lucini F, et al. Psychiatric Outcomes in ICU Patients With Family Visitation: A Population-Based Retrospective Cohort Study. Chest. 2022. PMID: 35271840. doi:10.1016/j.chest.2022.02.051

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。